These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia]. Song SQ; Zhang GN Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175 [TBL] [Abstract][Full Text] [Related]
4. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia]. Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278 [No Abstract] [Full Text] [Related]
5. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia. Lurain JR; Schink JC J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816 [TBL] [Abstract][Full Text] [Related]
6. Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary. Fülöp V; Szigetvári I; Szepesi J; Végh G; Berkowitz RS J Reprod Med; 2014; 59(5-6):227-34. PubMed ID: 24937962 [TBL] [Abstract][Full Text] [Related]
7. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years. Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247 [TBL] [Abstract][Full Text] [Related]
8. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. Lybol C; Thomas CM; Blanken EA; Sweep FC; Verheijen RH; Westermann AM; Boere IA; Reyners AK; Massuger LF; van Hoesel RQ; Ottevanger PB Eur J Cancer; 2013 Mar; 49(4):860-7. PubMed ID: 23099004 [TBL] [Abstract][Full Text] [Related]
9. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience. Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348 [TBL] [Abstract][Full Text] [Related]
10. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary. Fülöp V; Szigetvŕi I; Szepesi J; Török M; Berkowitz RS J Reprod Med; 2008 Jul; 53(7):541-6. PubMed ID: 18720931 [TBL] [Abstract][Full Text] [Related]
12. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia. Rattanaburi A; Boonyapipat S; Supasinth Y Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637 [TBL] [Abstract][Full Text] [Related]